$SPCX

SpaceX (SPCX) is expanding into AI infrastructure, with Oppenheimer raising its price target to $280 and increasing long-term revenue estimates by 10%. The firm highlights SPCX's vertical integration and Cursor acquisition, but notes significant capital expenditure risks. SPCX reported $15.83B in AI segment capex for Q2, with a $1.26B operating loss. Hedge funds have shown strong interest in the stock.

A trader bet $10M on SpaceX (SPCX) reclaiming $175 by January 2028, a level not seen since June. Oppenheimer raised its price target to $280. Tesla (TSLA) saw $900M in bullish options flow ahead of Musk's Cybercab event. SPCX is up 22.86% from its August low, while TSLA gained 10.85% over the past month.

SpaceX (SPCX) rose 7% to $150.84 ahead of Starship test 14, while Tesla (TSLA) gained 7% to $381.69 due to autonomy optimism and ties to SpaceX. Rocket Lab (RKLB) saw minimal movement despite strong earnings. The Procure Space ETF (UFO) and S&P 500 ETF (SPY) showed limited gains, indicating the rally is focused on Musk-linked stocks.

Nvidia, known for AI data centers, has invested $63.4B, with 75% in Intel and SpaceX. Intel investment, at $23.28/share, is now worth $30B. SpaceX stake, from xAI investment, is valued at $21B. Intel's partnership aids its turnaround, while SpaceX's future is uncertain due to losses.

Oppenheimer analyst Timothy Horan raised SpaceX's (SPCX) 12-month price target to $280 from $250, citing AI infrastructure growth and the Cursor acquisition. SPCX trades at $140.03, with a potential 99.96% upside. Oppenheimer also increased long-term revenue estimates by 10-20%. 33 analysts average a $231.63 target, up 64.61%. SPCX is up 3.73% since IPO, with a $1.9T market cap.

SPCX stock rose 0.50% premarket after Oppenheimer raised its price target to $280, citing SpaceX's AI platform and higher revenue estimates. Oppenheimer maintained an 'outperform' rating, and other firms like Bernstein and JPMorgan also issued positive ratings. SpaceX's Q1 revenue grew 92% to $7.81B, with a net loss of $541M. The stock has gained over 30% in a month, trading at $142.97.

SpaceX (SPCX) and Anthropic are set for large IPOs in 2026. SpaceX, valued at $1.8T, raised $85B, with Starlink driving growth. Anthropic aims for a $2T valuation, raising $100B, showing strong revenue growth and profitability. Both have ambitious market opportunities.

Nvidia (NVDA) will supply AI chips for SpaceX's (SPCX) orbital satellites, launching in Q4 2027. Nvidia owns 122.8M SpaceX shares. Revenue impact is uncertain until at least 2029, with technical and regulatory challenges ahead.

On September 9, 319 million SpaceX (SPCX) insider shares will unlock, the third in a series of post-IPO events. The November earnings unlock is expected to release 1.3 billion shares, four times September's amount. SPCX closed at $141.50 on August 31, down 37% from its June high. Analysts note that SPV distribution lags may affect actual trading volumes. The company's float is expanding, with more unlocks scheduled through October.

SpaceX (SPCX) reported $7.8B revenue and $18.4B in capital expenditures for Q2, with $15.8B spent on AI infrastructure. The company is investing heavily in AI, Starlink, and Starship, aiming to meet high demand. SpaceX has $100B in cash and strong profits from Starlink, but investors must assess if returns will justify spending.